Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mallinckrodt's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-1,098 Mil. Mallinckrodt's Total Assets for the quarter that ended in Sep. 2023 was $4,795 Mil.
Therefore, Mallinckrodt's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was -0.23.
The historical rank and industry rank for Mallinckrodt's Equity-to-Asset or its related term are showing as below:
MCKPF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.23 Med: 0.3 Max: 0.44
Current: -0.23
During the past 12 years, the highest Equity to Asset Ratio of Mallinckrodt was 0.44. The lowest was -0.23. And the median was 0.30.
MCKPF's Equity-to-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.59
vs MCKPF: -0.23
Mallinckrodt Equity-to-Asset Historical Data
The historical data trend for Mallinckrodt's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mallinckrodt's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, Mallinckrodt's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mallinckrodt's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mallinckrodt's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Mallinckrodt's Equity-to-Asset falls into.
Mallinckrodt Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Mallinckrodt's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Mallinckrodt Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Mallinckrodt's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which include specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MCKPF has been successfully added to your 